7PDD image
Deposition Date 2021-08-05
Release Date 2022-01-19
Last Version Date 2024-07-17
Entry Detail
PDB ID:
7PDD
Title:
Focus refinement of soluble domain of Adenylyl cyclase 9 in complex with DARPin C4 and MANT-GTP
Biological Source:
Source Organism:
Bos taurus (Taxon ID: 9913)
synthetic construct (Taxon ID: 32630)
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Adenylate cyclase 9
Gene (Uniprot):ADCY9
Chain IDs:A
Chain Length:1354
Number of Molecules:1
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:DARPin C4
Chain IDs:B
Chain Length:147
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Structural basis of adenylyl cyclase 9 activation.
Nat Commun 13 1045 1045 (2022)
PMID: 35210418 DOI: 10.1038/s41467-022-28685-y

Abstact

Adenylyl cyclase 9 (AC9) is a membrane-bound enzyme that converts ATP into cAMP. The enzyme is weakly activated by forskolin, fully activated by the G protein Gαs subunit and is autoinhibited by the AC9 C-terminus. Although our recent structural studies of the AC9-Gαs complex provided the framework for understanding AC9 autoinhibition, the conformational changes that AC9 undergoes in response to activator binding remains poorly understood. Here, we present the cryo-EM structures of AC9 in several distinct states: (i) AC9 bound to a nucleotide inhibitor MANT-GTP, (ii) bound to an artificial activator (DARPin C4) and MANT-GTP, (iii) bound to DARPin C4 and a nucleotide analogue ATPαS, (iv) bound to Gαs and MANT-GTP. The artificial activator DARPin C4 partially activates AC9 by binding at a site that overlaps with the Gαs binding site. Together with the previously observed occluded and forskolin-bound conformations, structural comparisons of AC9 in the four conformations described here show that secondary structure rearrangements in the region surrounding the forskolin binding site are essential for AC9 activation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures